Stories 1 - 20 |  Next >>

Trump's Vaccine Chief Fired for 'Unacceptable' Behavior

GSK says allegations of sexual harassment against Slaoui were 'substantiated'

(Newser) - A swift fall from grace for Dr. Moncef Slaoui, who led the Trump's administration's Operation Warp Speed effort to develop and distribute COVID vaccines: Slaoui has been fired as chairman of the board of directors at Galvani Bioelectronics over sexual harassment allegations, NBC reports. GlaxoSmithKline, Galvani's parent...

Fauci: We Could Have Vaccine This Year
Fauci: We Could Have
Vaccine This Year
the rundown

Fauci: We Could Have Vaccine This Year

He's 'cautiously optimistic'

(Newser) - Dr. Anthony Fauci reaffirmed Friday that the first coronavirus vaccine could be available to Americans before the end of the year. "We hope that as ... we get into the late fall and early winter we will have, in fact, a vaccine that we can say would be safe and...

2 Antidepressants Linked to Birth Defects
2 Antidepressants Linked
to Birth Defects 

2 Antidepressants Linked to Birth Defects

Paxil and Prozac implicated; newer SSRIs like Zoloft, Celexa cleared

(Newser) - A CDC study of almost 28,000 women has shown links between use of the antidepressants Paxil and Prozac and birth defects, Reuters reports. The study, published in the British Medical Journal , sought to answer long-debated questions about the effect of taking selective serotonin reuptake inhibitors, or SSRIs, during pregnancy,...

Ex-Smokers Jittery About 'Magic' Lozenge Shortage

Some who've relied on Nicorette suckers for years are hoarding them

(Newser) - Nicotine-replacement therapies are often a lifesaver for former smokers who want to make sure they kick the habit forever. But while gum and patches may do the trick for certain ex-inhalers, there's a product that, its loyal followers say, is the only smoking-cessation remedy that's worked for them:...

Ebola Vaccine Passes First Test

Initial results in small study are promising

(Newser) - The world took a small but significant step toward an Ebola vaccine today. Results of a study involving 20 people in the US found that the vaccine worked well enough to move on to round two—a much bigger test group of thousands of people in Africa, reports USA Today...

An AIDS Shot? Tests Raise Hope of Easier Prevention

Monkeys who got injection were protected from disease

(Newser) - Successful tests on monkeys suggest that people at risk of AIDS might be able to get a shot every three months or so to keep them healthy, reports AP . In two separate tests, each monkey that got an injection of anti-AIDS drugs remained protected for weeks after exposure, unlike those...

Glaxo: We'll Stop Paying Doctors to Hawk Our Drugs

It's a big change in pharma industry

(Newser) - In what "appears to be a first for a major drug company," according to the New York Times , GlaxoSmithKline will stop paying doctors to promote its drugs under a new plan to be completed by 2016. The company's pharmaceutical sales reps will also no longer be paid...

Drug Giant's Secret to Success Is Bribery: Cops

China says it busts scheme by Glaxo, travel agencies to bribe doctors

(Newser) - China says it knows how a few Shanghai travel agencies were managing huge revenues without many bookings, and the explanation isn't pretty: They were involved in an extensive bribery scheme with executives from drug giant GlaxoSmithKline, authorities say. The firms are accused of teaming up to bribe doctors and...

HPV Vaccine Price to Plummet for Poor Countries

Merck, GlaxoSmthKline will offer them for less than $5

(Newser) - Two of the world's biggest drug companies have agreed to slash the price of their HPV vaccines—which currently cost around $130 a dose in the US—down to less than $5 in some developing nations, the companies announced today. Thanks to a deal negotiated by the nonprofit GAVI...

New Fountain of Youth: Red Wine Pills

GlaxoSmithKline developing drugs based on resveratrol

(Newser) - You've no doubt heard that drinking red wine is good for your health. But scientists and Big Pharma alike are getting excited about putting the health-boosting essence of red wine in pill form. GlaxoSmithKline is working on a slew of new pills that do just that, the Daily Mail...

Swine Flu Shot May Have Caused Kids' Narcolepsy

795 European recipients of GlaxoSmithKline drug report illness

(Newser) - Children across Europe have been developing narcolepsy at increased rates since 2009—and experts fear the crisis may be linked to a GlaxoSmithKline swine flu vaccine. The incurable sleep disorder has surged in Sweden, Finland, Norway, France, and Britain, experts say, and it can take a devastating toll: Reuters recounts...

Critics Fume as Big Pharma Funds Drug Studies

'The evidence base has been perverted,' expert says

(Newser) - Think studies of new drugs in the New England Journal of Medicine are unassailable? Experts are beginning to wonder, because pharmaceutical companies pay academics to conduct many of those studies—and the approval of high-profile drugs like Vioxx, Avandia, and Celebrex has led to thousands of deaths, the Washington Post...

Glaxo Buying Human Genome Sciences
Glaxo Buying
Human Genome Sciences

Glaxo Buying Human Genome Sciences

After big drug failure in 2011, Human Genome failed to find higher bid

(Newser) - British pharma giant GlaxoSmithKline is poised to announce a $2.8 billion takeover of Human Genome Sciences, perhaps as early as today, reports Reuters . US-based Human Genome, which uses the human DNA sequence to develop drugs, balked at Glaxo's original $2.6 billion offer and said it would go...

Glaxo Paid Dr. Drew to Talk Up Drug for Depression

He got $200K over 2 months in 1999

(Newser) - GlaxoSmithKline this week agreed to pay $3 billion to settle a fraud case alleging that it took too many liberties in how it promoted its drugs, and Forbes notes a high-profile name mentioned in court documents: Dr. Drew Pinsky. Prosecutors said Glaxo paid Dr. Drew $275,000 over two months...

GlaxoSmithKline Settles Fraud Case for Record $3B

It's the largest penalty ever paid by a health care company in US

(Newser) - GlaxoSmithKline is about to set a new record: It's paying $3 billion in what government officials say is the largest health care fraud settlement in US history, the AP reports. The company will plead guilty to charges related to three drugs, the Justice Department says: Prosecutors say GSK promoted...

Disgraced Doctors Land at Big Pharma
 Disgraced Doctors 
 Land at Big Pharma 


Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(Newser) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the...

FDA Restricts Diabetes Drug Over Heart Risk

But regulators stop short of an outright ban on Avandia

(Newser) - The FDA today put severe restrictions on Avandia, GlaxoSmithKline’s embattled diabetes drug, but stopped short of banning it outright. The once-popular drug will now only be available only as a last resort to type 2 diabetes patients who can’t control their glucose levels with any other medication, the...

FDA Panel: Keep Avandia on Market

But it may get warning label on heart risks

(Newser) - A majority of federal health experts has voted to keep the controversial diabetes pill Avandia on the market despite evidence that it increases the risk of heart attack. A panel of Food and Drug Administration advisers voted 20-12 against withdrawing GlaxoSmithKline's once-blockbuster drug. The agency is not required to follow...

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

(Newser) - As the FDA prepares to consider whether to ban Avandia, agency scientists have discovered another problem with the diabetes drug: flaws that disqualify a clinical study sponsored by its maker. The trial, organized by GlaxoSmithKline, sought to evaluate the relative heart risks of Avandia and two other diabetes drugs, but...

Diabetes Drug Linked to Heart Woes Again; FDA Weighs Ban

Avandia less safe than alternatives; FDA weighs action

(Newser) - The mountain of evidence against diabetes drug Avandia grew a bit bigger today, with two major studies linking the medication to heart disease and stroke, the LA Times reports. An FDA panel will meet next month to discuss recalling the drug, which has been on the agency's radar at least...

Stories 1 - 20 |  Next >>